4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000111
Chief Medical Officer sold 3,302 shares at $43.92 ($145,024)
- Chief Medical Officer acquired 3,302 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Gheuens Sarah · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-27 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,302 | $25.01 | $82,583 | 65,029 | D |
| 2025-10-27 | Sale : show line 2 in the form 10b5-1 | −3,302 | $43.92 | $145,024 | 61,727 | D |
| Open-market sales · 3,302 sh · avg $43.92 · $145,024 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-10-27 | Exercise or conversion : show line 3 in the form 10b5-1 Stock options (right to buy) | −3,302 | 28,784 | D |
Loading xslF345X05/wk-form4_1761768146.xml…